Prevention of fat-induced insulin resistance by salicylate
AUTOR(ES)
Kim, Jason K.
FONTE
American Society for Clinical Investigation
RESUMO
Insulin resistance is a major factor in the pathogenesis of type 2 diabetes and may involve fat-induced activation of a serine kinase cascade involving IKK-β. To test this hypothesis, we first examined insulin action and signaling in awake rats during hyperinsulinemic-euglycemic clamps after a lipid infusion with or without pretreatment with salicylate, a known inhibitor of IKK-β. Whole-body glucose uptake and metabolism were estimated using [3-3H]glucose infusion, and glucose uptake in individual tissues was estimated using [1-14C]2-deoxyglucose injection during the clamp. Here we show that lipid infusion decreased insulin-stimulated glucose uptake and activation of IRS-1–associated PI 3-kinase in skeletal muscle but that salicylate pretreatment prevented these lipid-induced effects. To examine the mechanism of salicylate action, we studied the effects of lipid infusion on insulin action and signaling during the clamp in awake mice lacking IKK-β. Unlike the response in wild-type mice, IKK-β knockout mice did not exhibit altered skeletal muscle insulin signaling and action following lipid infusion. In summary, high-dose salicylate and inactivation of IKK-β prevent fat-induced insulin resistance in skeletal muscle by blocking fat-induced defects in insulin signaling and action and represent a potentially novel class of therapeutic agents for type 2 diabetes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=209353Documentos Relacionados
- Role of the glucosamine pathway in fat-induced insulin resistance.
- PKC-θ knockout mice are protected from fat-induced insulin resistance
- Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle
- Is “fat-induced” muscle insulin resistance rapidly reversible?
- Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease